PharmaLink, Inc., a leading pharmaceutical reverse distributor, announced its acquisition of Cybornetic Systems, Inc. dba PharmaReturns, Inc. In addition to expanding its national account base with top-tier clients, the purchase provides PharmaLink with an innovative technology platform for returns processing that adds artificial intelligence (AI) and new levels of customization to the reverse distribution process for pharmaceutical manufacturers. The Internet Managed Product Returns Solution (IMPRS) currently supports returns processing operations for over 400 pharmaceutical manufacturers in the United States. PharmaLink CEO & president, Thierry Beckers, was noted saying, "The leadership team at PharmaReturns has a long history of trailblazing innovation in our industry. With shared values of integrity, quality, customer focus, and innovation, this transaction was a natural fit that greatly benefits our business; and more importantly our customers." The transaction will be complete in June while systems integration runs through year-end 2023. The integration process will be carefully managed to ensure a smooth transition for both teams and prevent any disruption to ongoing client operations. Adam Bottie (vice president, corporate strategy & business development) stated, "We are excited to expand our offering and capabilities to the pharmaceutical manufacturing community, the integration of Encore and IMPRS is going to be a key element in our overall commitment to quality and a catalyst to ensure our competitive advantage in the space." As part of the acquisition, Cybornetic Systems, Inc., CyberCore Systems, Inc., PharmaReturns, Inc., and Return Product Solutions, Inc., as well as IMPRS and all other technology assets, will become the property of PharmaLink. PharmaLink, Inc. is the nation's premier Pharmaceutical Reverse Distribution provider. With services spanning the complete spectrum of the pharmaceutical supply chain, they have a 360
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!